Unique stem cell line identifier	NCHi015-A
Alternative name(s) of stem cell line	NCH178 (NCHi015-A)
Institution	Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH, USA
Contact information of distributor	Mingtao Zhao, PhD Mingtao.Zhao@nationwidechildrens.org
Type of cell line	iPSC
Origin	Human
Additional origin info required for human ESC or iPSC	Age: 1 year Sex: Male Race: Caucasian, Non-Hispanic
Cell Source	Peripheral Blood Mononuclear Cells (PBMC)
Clonality	Clonal
Method of reprogramming	Sendai Virus vectors
Genetic Modification	Yes
Type of Genetic Modification	Congenital
Evidence of the reprogramming transgene loss (including genomic copy if applicable)	RT-PCR KOS Transgene Negative (Supplementary Fig. 1C)
Associated disease	Truncus Arteriosus Type I
Gene/locus	KMT2D: c.2868G > C (12q13.12); NOTCH1: c.1099 + 1G > T (9q34.3)
Date archived/stock date	05/18/2023
Cell line repository/bank	NCHi015-A (NCH178) is deposited in the iPSC repository of pediatric cardiovascular disease in the Center for Cardiovascular Research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus, OH, USA.https://hpscreg.eu/cell-line/NCHi015-A
Ethical approval	Generation of this iPSC line was under an approved Institutional Review Board (IRB) protocol STUDY00001788 “iPSC Repository of Pediatric Cardiovascular Disease” at Nationwide Children’s Hospital.